GlassScriptPhysician profile
Michael J Knesek
NPI 1336376367
$10,816.37
in general payments reported to CMS, 2019-2025
29 companies · $1,005 in 2025
The $1,005 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,221 · 2020: $2,201 · 2021: $510 · 2022: $581 · 2023: $64.49 · 2024: $232 · 2025: $1,005.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,301.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,184.06 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Insignia |
| Medwest Associates | $2,282.78 | 2019-2020 | |
| Arthrex, INC. | $1,954.00 | 2019 | |
| Depuy Synthes Sales INC. | $183.40 | 2020-2025 | Monovisc |
| Smith+Nephew, INC. | $178.33 | 2021-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Kerecis Limited | $161.65 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Ferring Pharmaceuticals INC. | $128.08 | 2019-2022 | |
| Lightbody Medical Technologies INC | $100.97 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $72.02 | 2019-2025 | Tapestry, Persona |
| Orthofix Medical, INC. | $70.50 | 2022-2025 | Physio-Stim |
| Bioventus LLC | $60.25 | 2019-2022 | |
| Vertex Pharmaceuticals Incorporated | $50.31 | 2025 | |
| Vericel Corporation | $45.29 | 2022-2024 | Maci |
| Convatec INC. | $43.81 | 2021-2025 | |
| Electronic Waveform Lab, INC. | $43.35 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $28.21 | 2025 | Surgiphor |
| Intellijoint Surgical INC. | $25.64 | 2019-2020 | |
| Medtronic, INC. | $24.69 | 2021-2022 | |
| Carbofix Orthopedics INC | $19.76 | 2024 | |
| Integra Lifesciences Corporation | $18.99 | 2022 | |
| Linvatec Corporation | $18.95 | 2025 | Biobrace 23mm |
| Amgen INC. | $18.51 | 2023 | Evenity, Prolia |
| Djo, LLC | $16.34 | 2022 | |
| Medacta USA, INC. | $16.18 | 2022 | |
| Mallinckrodt Enterprises LLC | $16.13 | 2019 | |
| Ethicon US, LLC | $14.55 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $14.47 | 2019 | |
| Organogenesis INC. | $12.91 | 2022 | |
| Horizon Therapeutics Plc | $12.24 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Knesek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.